Modeling delayed drug effect using discrete-time nonlinear autoregressive models: a connection with indirect response models
暂无分享,去创建一个
An Vermeulen | Hui Wang | Xu Steven Xu | A. Vermeulen | X. Xu | Hui Wang
[1] State Space Representation of an Autoregressive Linear Mixed Effects Model for the Analysis of Longitudinal Data , 2008 .
[2] William J. Jusko,et al. Pharmacokinetic/Pharmacodynamic Modelling in Diabetes Mellitus , 2008, Clinical pharmacokinetics.
[3] M. A. Plant. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality , 1991 .
[4] Johan Gabrielsson,et al. Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications , 2002 .
[5] Arnold Neumaier,et al. Introduction to Numerical Analysis , 2001 .
[6] M. Feinleib,et al. Statistical Models for Longitudinal Studies of Health , 1992 .
[7] James W T Yates. Mathematical properties and parameter estimation for transit compartment pharmacodynamic models. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[8] Varun Garg,et al. Comparison of four basic models of indirect pharmacodynamic responses , 1993, Journal of Pharmacokinetics and Biopharmaceutics.
[9] J. Cohn,et al. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. , 1982, The American journal of cardiology.
[10] P. Diggle,et al. Analysis of Longitudinal Data , 2003 .
[12] W. Jusko,et al. Pharmacokinetics/dynamics of 5c8, a monoclonal antibody to CD154 (CD40 ligand) suppression of an immune response in monkeys. , 1998, The Journal of pharmacology and experimental therapeutics.
[13] Mathematical Assessment of Properties of Precursor-Dependent Indirect Pharmacodynamic Response Models , 2006, Journal of Pharmacokinetics and Pharmacodynamics.
[14] W J Jusko,et al. Physiologic indirect response models characterize diverse types of pharmacodynamic effects , 1994, Clinical pharmacology and therapeutics.
[15] W. Jusko,et al. Mathematical Formalism for the Properties of Four Basic Models of Indirect Pharmacodynamic Responses , 1997, Journal of Pharmacokinetics and Biopharmaceutics.
[16] K. Swedberg,et al. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.
[17] R. Ramakrishnan,et al. Basic Pharmacodynamic Models for Agents That Alter Production of Natural Cells , 1999, Journal of Pharmacokinetics and Biopharmaceutics.
[18] F. Speizer,et al. The use of an autoregressive model for the analysis of longitudinal data in epidemiologic studies. , 1985, Statistics in medicine.
[19] W. Jusko,et al. Population Pharmacokinetics and Pharmacodynamics of Peptidic Erythropoiesis Receptor Agonist (ERA) in Healthy Volunteers , 2008, Journal of clinical pharmacology.
[20] M O Karlsson,et al. Pharmacodynamic models for the cardiovascular effects of moxonidine in patients with congestive heart failure. , 2001, British journal of clinical pharmacology.
[21] J. Lindsey. Models for Repeated Measurements , 1993 .
[22] C H Schmid,et al. Marginal and dynamic regression models for longitudinal data , 2001, Statistics in medicine.
[23] B Rosner,et al. Autoregressive modelling for the analysis of longitudinal data with unequally spaced examinations. , 1988, Statistics in medicine.
[24] Wojciech Krzyzanski,et al. Indirect Pharmacodynamic Models for Responses with Multicompartmental Distribution or Polyexponential Disposition , 2001, Journal of Pharmacokinetics and Pharmacodynamics.
[25] Y. Ohashi,et al. An autoregressive linear mixed effects model for the analysis of longitudinal data which show profiles approaching asymptotes , 2007, Statistics in medicine.
[26] W. Jusko,et al. ALGORITHM FOR APPLICATION OF FOURIER ANALYSIS FOR BIORHYTHMIC BASELINES OF PHARMACODYNAMIC INDIRECT RESPONSE MODELS , 2000, Chronobiology international.
[27] Hulin Wu,et al. Mixed‐Effects State‐Space Models for Analysis of Longitudinal Dynamic Systems , 2011, Biometrics.
[28] W J Jusko,et al. Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena. , 1998, Journal of pharmaceutical sciences.
[29] Christopher H. Schmid. An EM Algorithm Fitting First-Order Conditional Autoregressive Models to Longitudinal Data , 1996 .
[30] W J Jusko,et al. Characteristics of indirect pharmacodynamic models and applications to clinical drug responses. , 1998, British journal of clinical pharmacology.
[31] Mats O. Karlsson,et al. Approaches to handling pharmacodynamic baseline responses , 2008, Journal of Pharmacokinetics and Pharmacodynamics.
[32] W. Jusko,et al. Characterization of four basic models of indirect pharmacodynamic responses , 1996, Journal of Pharmacokinetics and Biopharmaceutics.
[33] Cheng Hsiao,et al. Formulation and estimation of dynamic models using panel data , 1982 .